Riskpilot← Back to searchSign inGet full accessAloVita AB
ABActiveOrg 5568620115Havrevägen 13Physiotherapy activities · NACE 8695Est. 20110 employees
Revenue 2025
SEK -1
-100% vs 2024
EBITDA margin
7617200.0%
-286% vs 2024
Equity ratio
85.3%
Financial strength
Net profit 2025
SEK 1K
-100% vs 2024
| Revenue | SEK -1 | -100% |
| EBITDA | SEK -76K | -286% |
| Net profit | SEK 1K | -100% |
| Total assets | SEK 460K | -40% |
| Equity | SEK 392K | +0% |
| Employees | 0 | — |
Legal name
AloVita AB
Org number
5568620115
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
23 augusti 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva arbetsterapeutiska åtgärder inom primärvården och företagshälsovård och annan förenlig verksamhet, personaluthyrning, utbildning, försäljning och anpassning av ergonomiska och tekniska produkter såsom handdator och mobiltelefoner samt därmed förenlig verksamhet. Bolaget ska bedriva trädgårdsrehabilitering, turism, försäljning av tjänster och varor.
Address
Havrevägen 13
Email
annlo@alovita.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 510 | 986 | 936 | 212 | −0 |
| Staff expenses | — | −302 | — | −22 | −0 |
| EBITDA | 527 | 330 | 648 | 41 | −76 |
| Depreciation & amort. | −33 | −27 | −47 | −62 | −66 |
| EBIT | 494 | 303 | 601 | −22 | −142 |
| Net financials | — | −0 | — | −0 | 1 |
| Profit before tax | 342 | 256 | 525 | 424 | 2 |
| Tax | −75 | −74 | −111 | −94 | −1 |
| Net profit | 267 | 182 | 414 | 331 | 1 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 382 | 1 392 | 1 442 | 763 | 460 |
| Equity | 765 | 347 | 760 | 391 | 392 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 105 | 486 | 46 | 182 | 21 |
| Total debt | 105 | 486 | 46 | 182 | 21 |
EBITDA margin
-7617200.0%
This company
15.8%
Market median
-48210227% vs market
20212025
Equity ratio
85.3%
This company
38.2%
Market median
+123% vs market
20212025
Return on equity
0.3%
This company
18.4%
Market median
-98% vs market
20212025
Net profit margin
117500.0%
This company
8.1%
Market median
+1450517% vs market
20212025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AloVita AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ann-Louise Lövgren Engström | Board of Directors | 0 companies |
| Daniel Emil Engström | Deputy Board Member | 0 companies |